Preservation of Ovarian Function After Hematopoietic Cell Transplant

NCT01343368 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Conditions

Multiple Myeloma
Non-Hodgkin Lymphoma
Hodgkin Disease
Acute Myeloid Leukemia
Myeloproliferative Disorders

Interventions

DRUG: Leuprolide
BIOLOGICAL: hematopoietic cell transplant
BIOLOGICAL: reduced intensity allogeneic HCT

Sponsor

Masonic Cancer Center, University of Minnesota

Collaborators

[object Object]